← Full daily brief

Mass Tort brief

Corporate Shields and Liability Pressures

Teva faces expanding injury litigation in the United States, while Israeli courts act to curb broad class-action exposure for multinational firms.

Signalpoint TeamBrief

Mass Tort

Teva’s mounting product liability and contamination lawsuits in the US sustain long-term litigation pressure — threatening the drugmaker’s precarious effort to pay down its massive debt.

BackgroundMultidistrict litigation consolidates complex civil cases from different districts to expedite pretrial proceedings and encourage settlements. Teva remains highly exposed to US class actions, which historically depressed its share price on the Tel Aviv Stock Exchange.

Points
  1. The total number of active personal injury cases in the ParaGard copper IUD multidistrict litigation has climbed to nearly 4,000, raising the risk of a costly global settlement.
  2. Teva is also fighting a separate class action over generic blood pressure medication Valsartan contaminated with high levels of carcinogenic NDMA, expanding its US product liability battlefront.
  3. A final court approval hearing is set for August 12 regarding Teva's $3M portion of a Metformin contamination settlement, representing a minor but symbolic resolution of its manufacturing issues.

Mass Tort

Israeli courts are building protective barriers for multinational corporations — a shift that penalizes speculative filings and shields foreign travel giants from global-scale damages.

BackgroundClass actions in Israel allow consumer groups to sue on behalf of large populations, serving as a key regulatory watchdog. Israeli courts historically exercised extreme restraint when ordering unsuccessful plaintiffs to pay legal fees, making filings low-risk.

Points
  1. The Supreme Court signaled a shift toward penalizing applicants who file weak or delayed class actions with heavier legal costs, which will likely deter speculative litigation.
  2. The Lod District Court ruled that certified class actions against Booking.com and Expedia may only represent Israeli citizens and residents, shielding corporate defendants from global-scale liabilities.
  3. The jurisdictional ruling prevents plaintiffs from including foreign nationals who booked Israeli hotels from abroad, significantly limiting the financial damages multinational firms face in domestic courts.

Unlock the full brief

Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.